Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01699867 · ClinicalTrials.gov registry record
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)
A clinical trial of Breast Cancer, sponsored by Diagnostic Photonics.
- Completed
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT01699867: Completed study of Breast Cancer, sponsored by Diagnostic Photonics.
NCT01699867 is a study of Breast Cancer that has completed, run by Diagnostic Photonics. The registered enrollment target is 50 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01699867, a study of Breast Cancer, has completed, sponsored by Diagnostic Photonics.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This multi-center, prospective, open label study analyzed specimens from fifty subjects at two study sites. Patients scheduled to undergo breast-conserving surgery were recruited in accordance with the inclusion and exclusion criteria. The study period per subject was the time it took to assess the ex vivo breast tissue sample using the study device. Image review was conducted after surgery and compared to the margin status findings in the post-operative pathology report.
Conditions Studied
Interventions
- DEVICE Optical coherence tomography
Study Locations (2)
Maryland
- Anne Arundel Medical Center - Annapolis
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01699867
The ClinicalTrials.gov registry entry for NCT01699867 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Diagnostic Photonics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Optical coherence tomography is the first listed.
NCT01699867 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01699867 about?
NCT01699867 is a clinical study titled "Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)". This multi-center, prospective, open label study analyzed specimens from fifty subjects at two study sites. Patients scheduled to undergo breast-conserving surgery were recruited in accordance with the inclusion and exclusion criteria. The study period per subject was the time it took to assess the ...
What is the current status of trial NCT01699867?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-12. Estimated completion is 2014-04.
What conditions does trial NCT01699867 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01699867?
The interventions under investigation include: Optical coherence tomography (DEVICE).
Who is sponsoring clinical trial NCT01699867?
This trial is sponsored by Diagnostic Photonics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01699867 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.